Benign prostatic hyperplasia
119 results
1 - 100
Benign prostatic hyperplasia - Pygeum africanum for benign prostatic hyperplasia
Beta‐sitosterols for benign prostatic hyperplasia- Tamsulosin for benign prostatic hyperplasia
- Pygeum africanum for benign prostatic hyperplasia
- Serenoa repens for benign prostatic hyperplasia
- Terazosin for benign prostatic hyperplasia
- Phytotherapy for benign prostatic hyperplasia
- 5-alpha-reductase inhibitors (5ARI) for benign prostatic hyperplasia
- Finasteride for benign prostatic hyperplasia
- Transurethral microwave thermotherapy for benign prostatic hyperplasia
- Cernilton for benign prostatic hyperplasia: Cochrane systematic review
Minimal benefit with adding antimuscarinics to alpha-blockers for benign prostatic hyperplasia- Terazosin for benign prostatic hyperplasia: Cochrane systematic review
- Tamsulosin for benign prostatic hyperplasia: Cochrane systematic review
- Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia
- Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia
- Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia
- Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia
- Convective radiofrequency water vapour thermal therapy for lower urinary tract symptoms in men with benign prostatic hyperplasia
- Transurethral microwave thermotherapy for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia
- Combination of doxazosin and finasteride compared with either drug alone or placebo for benign prostatic hyperplasia
- Silodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia
- Aquablation of the prostate for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia
- Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia: Cochrane systematic review
- Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta‐analysis
- Physical activity for lower urinary tract symptoms secondary to benign prostatic obstruction
- Chronic prostatitis
- Transurethral resection of the prostate for prostatic hyperplasia
- Tadalafil effective for benign prostatic hypertrophy
- Urinary retention
- Urinary incontinence in the elderly
- Poor urine flow
- Holmium:YAG laser in urology
- Acute bacterial prostatitis
- Urinary frequency (pollakiuria) and nocturia
- Oral desmopressin effective for nocturnal polyuria in men with BPH
- High-dose saw palmetto no better than placebo for BPH symptoms
- Men who take terazosin, doxazosin, or alfuzosin rather than tamsulosin or 5α-reductase inhibitors are less likely to develop Lewy body dementia
- PSA test in prostate cancer screening
- 5-a reductase inhibitor use prior to prostate cancer diagnosis is not associated with increased mortality